Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials

The Lancet - Tập 370 - Trang 1483-1493 - 2007
Masafumi Kitakaze1,2, Masanori Asakura1,2, Jiyoong Kim1, Yasunori Shintani3, Hiroshi Asanuma4, Toshimitsu Hamasaki5, Osamu Seguchi1, Masafumi Myoishi1, Tetsuo Minamino3, Takahiro Ohara1, Yoshiyuki Nagai6, Shinsuke Nanto7, Kouki Watanabe8, Shigeru Fukuzawa9, Atsushi Hirayama10, Natsuki Nakamura11, Kazuo Kimura12, Kenshi Fujii13, Masaharu Ishihara14, Yoshihiko Saito15
1Cardiovascular Division of Medicine, National Cardiovascular Centre, Suita, Osaka, Japan
2Department of Clinical Research and Development, National Cardiovascular Centre, Suita, Osaka, Japan
3Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
4Research Institute, National Cardiovascular Centre, Suita, Osaka, Japan
5Department of Biomedical Statistics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
6Heart Centre Department of Cardiology, Rinku General Medical Centre, Izumisano, Osaka, Japan
7Cardiovascular Division, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan
8Department of Cardiology, Uwajima-City Hospital, Uwajima, Ehime, Japan
9Division of Cardiology, Funabashi Municipal Medical Centre, Funabashi, Chiba, Japan
10Cardiovascular Division, Osaka Police Hospital, Osaka, Osaka, Japan
11Department of Cardiology, Shinbeppu Hospital, Beppu, Oita, Japan
12Division of Cardiology, Yokohama City University Medical Centre, Yokohama, Kanagawa, Japan
13Division of Cardiology, Sakurabashi Watanabe Hospital, Osaka, Osaka, Japan
14Department of Cardiology, Hiroshima City Hospital, Hiroshima, Hiroshima, Japan
15First Department of Medicine, Nara Medical University, Kashihara, Nara, Japan

Tài liệu tham khảo

Thom, 2006, Heart disease and stroke statistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 113, 85, 10.1161/CIRCULATIONAHA.105.171600 Jessup, 2003, Heart failure, N Engl J Med, 348, 2007, 10.1056/NEJMra021498 Levy, 2002, Long-term trends in the incidence of and survival with heart failure, N Engl J Med, 347, 1397, 10.1056/NEJMoa020265 Shiba, 2005, Poor prognosis of Japanese patients with chronic heart failure following myocardial infarction—comparison with nonischemic cardiomyopathy, Circ J, 69, 143, 10.1253/circj.69.143 Kloner, 2004, Cardiac protection during acute myocardial infarction: where do we stand in 2004?, J Am Coll Cardiol, 44, 276, 10.1016/j.jacc.2004.03.068 1985, Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial, Eur Heart J, 6, 199, 10.1093/oxfordjournals.eurheartj.a061845 Ross, 2005, A randomised, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II), J Am Coll Cardiol, 45, 1775, 10.1016/j.jacc.2005.02.061 van der Horst, 2003, Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomised trial, J Am Coll Cardiol, 42, 784, 10.1016/S0735-1097(03)00830-1 Grines, 1993, A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group, N Engl J Med, 328, 673, 10.1056/NEJM199303113281001 Sakurai, 2003, Comparison of the efficacy of reperfusion therapies for early mortality from acute myocardial infarction in Japan: registry of Miyagi Study Group for AMI (MsAMI), Circ J, 67, 209, 10.1253/circj.67.209 Lamas, 1995, Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators, Circulation, 92, 1101, 10.1161/01.CIR.92.5.1101 Verma, 2002, Fundamentals of reperfusion injury for the clinical cardiologist, Circulation, 105, 2332, 10.1161/01.CIR.0000016602.96363.36 Zeymer, 2001, The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial, J Am Coll Cardiol, 38, 1644, 10.1016/S0735-1097(01)01608-4 1994, The ESPRIM trial: short-term treatment of acute myocardial infarction with molsidomine, Lancet, 344, 91 Wall, 1994, Intravenous fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group, Circulation, 90, 114, 10.1161/01.CIR.90.1.114 Cody, 1986, Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion, J Clin Invest, 78, 1362, 10.1172/JCI112723 Emori, 1993, Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells, Endocrinology, 133, 2474, 10.1210/endo.133.6.8243267 Kitakaze, 1996, Role of activation of ectosolic 5′-nucleotidase in the cardioprotection mediated by opening of K+ channels, Am J Physiol, 270, 1744 Mizumura, 1996, Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs, Cardiovasc Res, 32, 274, 10.1016/0008-6363(96)00061-2 Hayashi, 2001, Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction, J Am Coll Cardiol, 37, 1820, 10.1016/S0735-1097(01)01233-5 Kuga, 2003, Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction, Circ J, 67, 443, 10.1253/circj.67.443 Sugimoto, 2003, Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction, Circ J, 67, 295, 10.1253/circj.67.295 Sakata, 1997, Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction, Am Heart J, 133, 616, 10.1016/S0002-8703(97)70162-5 Fukuzawa, 2000, Nicorandil affords cardioprotection in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty: assessment with thallium-201/iodine-123 BMIPP dual SPECT, J Nucl Cardiol, 7, 447, 10.1067/mnc.2000.107273 Ishii, 2005, Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction, Circulation, 112, 1284, 10.1161/CIRCULATIONAHA.104.530329 Asakura, 2004, Circ J, 68, 95, 10.1253/circj.68.95 Minamino, 2004, Circ J, 68, 101, 10.1253/circj.68.101 Seino, 1996, Pathophysiological analysis of serum troponin T release kinetics in evolving ischemic myocardial injury, Jpn Circ J, 60, 265, 10.1253/jcj.60.265 Steen, 2006, Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function, J Am Coll Cardiol, 48, 2192, 10.1016/j.jacc.2006.06.002 Vollmer, 1993, Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal function, Am J Clin Pathol, 100, 293, 10.1093/ajcp/100.3.293 Therneau, 2000 Hess, 1995, Graphical methods for assessing violations of the proportional hazards assumption in Cox regression, Stat Med, 14, 1707, 10.1002/sim.4780141510 Mahaffey, 1999, Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomised, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial, J Am Coll Cardiol, 34, 1711, 10.1016/S0735-1097(99)00418-0 Grover, 1992, Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors, Circulation, 86, 1310, 10.1161/01.CIR.86.4.1310 2002, Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial, Lancet, 359, 1269, 10.1016/S0140-6736(02)08265-X